346 related articles for article (PubMed ID: 21571956)
1. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
Hornick JL; Fletcher CD
Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
4. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour.
Kang GH; Kim KM; Park CK; Kang DY
Histopathology; 2009 Sep; 55(3):368-9. PubMed ID: 19723158
[No Abstract] [Full Text] [Related]
5. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
6. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors.
Folpe AL; Schmidt RA; Chapman D; Gown AM
Am J Surg Pathol; 1998 Jun; 22(6):673-82. PubMed ID: 9630174
[TBL] [Abstract][Full Text] [Related]
8. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
9. A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone.
Verbeke SL; Fletcher CD; Alberghini M; Daugaard S; Flanagan AM; Parratt T; Kroon HM; Hogendoorn PC; Bovée JV
Am J Surg Pathol; 2010 Jun; 34(6):777-83. PubMed ID: 20421780
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study.
Qureshi MB; Uddin N; Tariq MU; Raheem A; Pervez S
Cureus; 2019 Dec; 11(12):e6357. PubMed ID: 31938642
[TBL] [Abstract][Full Text] [Related]
11. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
12. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma.
Atef A; Alrashidy M
Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872
[TBL] [Abstract][Full Text] [Related]
13. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
14. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma.
Olsen SH; Thomas DG; Lucas DR
Mod Pathol; 2006 May; 19(5):659-68. PubMed ID: 16528378
[TBL] [Abstract][Full Text] [Related]
15. TLE1 expression fails to distinguish between synovial sarcoma, atypical fibroxanthoma, and dermatofibrosarcoma protuberans.
Pukhalskaya T; Smoller BR
J Cutan Pathol; 2020 Feb; 47(2):135-138. PubMed ID: 31614009
[TBL] [Abstract][Full Text] [Related]
16. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China.
Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H
Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.
Rekhi B; Basak R; Desai SB; Jambhekar NA
Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123
[TBL] [Abstract][Full Text] [Related]
18. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
19. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
Mod Pathol; 2000 Dec; 13(12):1336-46. PubMed ID: 11144931
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors.
Schildhaus HU; Riegel R; Hartmann W; Steiner S; Wardelmann E; Merkelbach-Bruse S; Tanaka S; Sonobe H; Schüle R; Buettner R; Kirfel J
Hum Pathol; 2011 Nov; 42(11):1667-75. PubMed ID: 21531005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
